Guide for Aviation Medical Examiners
Pharmaceuticals (Therapeutic Medications)
- Code of Federal Regulations
Medical History - Mefloquine (Lariam) is associated with adverse neuropsychiatric side-effects, even weeks after the drug is discontinued. This medication is absolutely disqualifying for pilots. Because of the association with adverse neuropsychiatric side-effects, even weeks after discontinuation, a pilot who elects to use mefloquine for malaria prophylaxis or who contracts malaria and is treated with mefloquine will be disqualified for pilot duties for the duration of use of mefloquine and for 4 weeks after the last dose. In this instance, the pilot must contact the FAA or his/her Aviation Medical Examiner prior to returning to flight duties after use.
Aeromedical Decision Considerations - See Medical History section above.
Protocol - N/A
Pharmaceutical Considerations - See Medical History section above.
- First-Class Airman Medical Certificate: 67.113(c)
- Second-Class Airman Medical Certificate: 67.213(c)
- Third-Class Airman Medical Certificate: 67.313(c)
Page Last Modified: 03/10/11 09:33 EST